Solutions for Vaccine Innovation and Gene Therapy:
Unlocking the Power of RNA
About this webinar
RNA technologies have revolutionized the field of therapeutics, enabling breakthroughs in vaccine development and gene therapy.
Traditional mRNA-based approaches have shown immense potential, particularly in rapid vaccine deployment and gene replacement therapies. Building upon this foundation, self-amplifying RNA (saRNA) offers a significant advantage — prolonged protein expression with lower doses, increasing efficiency and reducing costs.
In this webinar, the expert speaker will explore the evolution from standard mRNA to saRNA, highlighting the benefits of this advanced platform. She will showcase how specialized saRNA technologies provide researchers with high-quality, custom solutions that support the realization of their innovative projects. Moreover, she will share how services right from gene synthesis to saRNA production with delivery solutions caters to requirements from both clinical and research settings.
Register for an insightful webinar exploring how next-generation RNA technologies can provide effective solutions for vaccine innovation and gene therapy.
Who should attend
- Vaccine development
- Gene therapy
- Biopharmaceuticals/Biotherapeutics
- Biotech
- Research and development
- Professionals interested in RNA technology advancements
- Clinical research/Clinical Scientists
What you will learn
- Fundamentals and applications of RNA technologies
- How saRNA is advancing vaccine and gene therapy development
- The differences between standard mRNA and self-amplifying RNA
- The unique benefits of saRNA in drug development and vaccine production
Featured Speakers
Juliana Campo Garcia
Juliana Campo Garcia has a background in neurobiology and immunology, where she focused on the characterization of regenerative niches in the adult brain and investigated the effects of invading immune cells on neural stem cells.
Since joining GenScript as Field Application Scientist, she has specialized in RNA and CRISPR technologies, expanding her knowledge base to provide expert technical support to customers.
Partner for this event
GenScript
GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to make people and nature healthier through biotechnology by scripting possibilities.
Related webinars
More from GenScript.
Fast-Tracking IVT mRNA Candidate Selection Through Smarter RNA Design
Emerging LNP Technology and mRNA Strategies for In Vivo CAR-T Development
Optimized Conjugation Solution for Precise Extrahepatic Delivery of Small Nucleic Acid Drug
AI in Molecular Biology: Revolutionizing the Future of Biotech
High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT
How Cell-Free mRNA Templates Support Faster Research with High-Quality and Quick Turnaround
Advancing Small Nucleic Acid Drug Development with a One-Stop Solution
Transforming Medicine: The Potential of Endothelial Cilia Proteins as Groundbreaking Biomarkers
Unlocking CRISPR: Advances in Base Editing, Prime Editing and Future Applications
Boost CRISPR Editing Efficiency Using Optimized sgRNA and HDR Template Design
Maximizing PK and ADA Evaluation Efficiency Using Cutting-Edge Rabbit Antibody Development Technology
Accelerating Cell and Gene Therapy Success with cGMP Gene Editing Components and Regulatory Compliance